http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-8200644-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3d743b59ae50ca79489082cb43339341
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D407-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D407-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D407-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-62
filingDate 1981-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a84862e80fb845b3b182c3e067f84ac
publicationDate 1982-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-8200644-A1
titleOfInvention 5,6-o-isoalkylidene ascorbic acid derivatives
abstract New condensation products between enediol cetolactones such as 5,6-0-isopropylidene ascorbic acid and 2-chloroethyl isocyanates showing potent anti-tumor activity probably without the release of alkylating agents in vivo . Although the structures of the products cannot be easily clarified, it appears that their activity is superior to that of BCNU (bis (2-chloroethyl) -N-nitrosourea) and parallel to that of nitrosourea NeCCNU (1- ( 4-trans-methylcyclohexyle) -3- (2-chlorotethyle) -3-nitrosouree), which is toxic and very effective. The preferred compounds are condensation products according to the formula (FORMULA) where R2 and R3 represent a lower alkyl group containing from 1 to 3 carbon atoms or H and hal-CH2-CH2-N = C = O (B) or hal represents I, Br or Cl.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0148094-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0148094-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4780549-A
priorityDate 1980-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3455912-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3965119-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2028309-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3074998-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S554324-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4111958-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID230837012
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396483
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID236367974
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2578
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68975358
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396074
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400370
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395501
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394438
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14090
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6337
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3950
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11177
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5198
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393724
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394110
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID230199334
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12679
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54676860
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226439876
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393829
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7765
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24749
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45051774
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393830
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129612731
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID105035
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128856490
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22825153

Total number of triples: 53.